Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the QXO-PB SEC filings page.
QXO, Inc. (QXO-PB) reported $6.8M in revenue for fiscal year 2025, up 11925.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The reported business is a low-margin operator whose 2025 investment program relied more on financing than internally generated cash.
In FY2025, the company reported a net loss of-$279K but generated operating cash flow of$261K and free cash flow of$183K , showing that accounting earnings and near-term cash movement diverged. That positive cash conversion was modest, however, relative to the$10.6M investing outflow, so cash generation did not fund the year’s major capital deployment.
Gross margin fell from
The
Financial Health Signals
QXO, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
QXO, Inc. passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
QXO, Inc. reported a net loss of $279K while generating $261K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
QXO, Inc. reported an operating loss of $245K against $174K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
QXO, Inc. generated $3.2B in revenue in Q2 2026. This represents an increase of 170204.3% from the same quarter a year earlier. Against the prior quarter it is up 87.6%.
QXO, Inc.'s EBITDA was $14.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 10394.1% from the same quarter a year earlier. Against the prior quarter it is up 106.8%.
QXO, Inc. reported -$55.0M in net income in Q2 2026. This represents a decrease of 93120.3% from the same quarter a year earlier. Against the prior quarter it is up 75.8%.
Cash & Balance Sheet
QXO, Inc. recorded an outflow of $248.1M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 127553.7% from the same quarter a year earlier. Against the prior quarter it is down 615.8%.
QXO, Inc. held $2.8B in cash against $6.0B in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
QXO, Inc.'s gross margin was 24.7% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 3.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.1 percentage points.
QXO, Inc.'s operating margin was -1.3% in Q2 2026, reflecting core business profitability. This is up 7.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 13.3 percentage points.
QXO, Inc.'s net profit margin was -1.7% in Q2 2026, showing the share of revenue converted to profit. This is up 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 11.4 percentage points.
QXO, Inc.'s ROE was -0.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.7 percentage points.
Capital Allocation
QXO, Inc. invested $31.5M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 158558.2% from the same quarter a year earlier. Against the prior quarter it is up 40.0%.
Not reported for Q2 2026.
Not reported for Q2 2026.
QXO-PB Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B+170204.3% | $1.7B+12716.3% | N/A | $2.7M-79.2% | $1.9M-86.9% | $13.5M-6.5% | N/A | $13.1M-2.4% |
| Cost of Revenue | $2.4B+162225.6% | $1.3B+16207.4% | N/A | $2.1M-72.5% | $1.5M-82.7% | $8.1M-7.7% | N/A | $7.6M-5.9% |
| Gross Profit | $803.0M+200149.4% | $409.3M+7479.6% | N/A | $636K-88.4% | $401K-93.1% | $5.4M-4.6% | N/A | $5.5M+2.8% |
| SG&A Expenses | $649.0M+141913.1% | $497.0M+1019.4% | N/A | $453K-98.8% | $457K-95.3% | $44.4M+755.5% | N/A | $39.0M+405.7% |
| Operating Income | -$42.0M-25666.9% | -$251.9M-541.0% | N/A | $26K+100.1% | -$163K+96.2% | -$39.3M-17336.8% | N/A | -$33.7M-1217.4% |
| EBITDA | $14.0M+10394.1% | -$204.6M-421.9% | N/A | $66K+100.2% | -$136K+96.8% | -$39.2M-8476.1% | N/A | -$33.7M-1326.8% |
| Interest Expense | $65.0M+124900.0% | $56.5M | N/A | $62K | $52K | $0-100.0% | N/A | $0-100.0% |
| Income Tax | -$22.0M-12259.6% | -$53.2M-725.9% | N/A | $129K-97.9% | -$178K+11.0% | $8.5M+12042.9% | N/A | $6.1M+1437.7% |
| Net Income | -$55.0M-93120.3% | -$227.1M-2680.7% | N/A | -$139K-100.8% | -$59K+90.2% | $8.8M+6276.8% | N/A | $17.2M+915.2% |
| EPS (Basic) | -$0.14+6.7% | -$0.35-1066.7% | -$0.17-1600.0% | -$0.24-2300.0% | -$0.15+98.5% | -$0.03-114.3% | -$0.01-101.6% | -$0.01+99.7% |
| EPS (Diluted) | -$0.14 | -$0.35-1066.7% | -$0.17-1600.0% | -$0.24-2300.0% | -$0.15 | -$0.03 | -$0.01 | -$0.01 |
| Diluted Shares (Avg) | 767M | 744M+64.9% | N/A | 715M+99.4% | 565M | 451M | N/A | 359M |
Not reported in any period shown, so not listed: R&D Expenses.
QXO-PB Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $22.7B+32.4% | $16.7B-99.7% | $15.9B+211.6% | $16.6B-99.7% | $17.1B-98.3% | $5.1T+24413.2% | $5.1B+24775.8% | $5.1T+27537906.7% |
| Current Assets | $10.3B+159227.5% | $6.5B+26.5% | $5.5B+9.0% | $6.2M-99.9% | $6.5M-99.3% | $5.1B+40647.3% | $5.1B+43046.8% | $5.1B+45703.2% |
| Cash & Equivalents | $2.8B+121646.8% | $3.0B-40.1% | $2.4B-53.4% | $2.3M-100.0% | $2.3M-99.8% | $5.1B+80823.9% | $5.1B+82408.5% | $5.0B+73118.9% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $2.1B+111924.2% | $1.7B | $1.5B | $1.7M | $1.8M | N/A | $0 | N/A |
| Accounts Receivable | $1.8B+112992.6% | $1.1B+34985.0% | $1.1B+42307.4% | $1.6M-30.1% | $1.6M-47.7% | $3.2M+21.6% | $2.7M-9.1% | $2.2M-17.0% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $6.2B+120786.0% | $5.1B+442089.7% | $5.1B+425816.7% | $5.1M+337.1% | $5.1M+350.7% | $1.2M+1.8% | $1.2M+5.3% | $1.2M+1.8% |
| Total Liabilities | $10.3B+43.4% | $6.5B-87.9% | $6.2B+13512.3% | $6.8B-65.7% | $7.2B-57.5% | $53.8B+306.0% | $45.4M+248.6% | $19.9B+175348.4% |
| Current Liabilities | $2.5B+116044.8% | $1.9B+3514.5% | $1.6B+3336.8% | $2.0M-89.6% | $2.2M-86.3% | $53.6M+347.7% | $45.1M+291.4% | $19.5M+85.3% |
| Non-Current Liabilities | $7.8B+55.2% | $4.6B+2437386.6% | $4.6B+1543233.3% | $4.8B+1416113.0% | $5.0B+455833.0% | $187K-85.4% | $300K-80.0% | $338K-56.8% |
| Long-Term Debt | $6.0B+97.6% | $3.1B | $3.1B | $3.1B | $3.1B+340.3% | N/A | $0-100.0% | $0-100.0% |
| Total Equity | $10.4B+104569.7% | $10.2B+100.9% | $9.7B+92.1% | $9.8M-99.8% | $9.9M-99.0% | $5.1B+66478.9% | $5.1B+67273.3% | $5.0B+71401.3% |
| Retained Earnings | -$761.0M-730927.9% | -$652.0M-3164.2% | -$395.0M-6271.0% | -$274K-105.5% | -$104K+95.7% | -$20.0M-1004.4% | -$6.2M-218.3% | $5.0M+310.6% |
QXO-PB Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$216.6M-124026.1% | $70.6M+93.4% | $186.6M+246.2% | $213K-99.3% | -$175K+83.6% | $36.5M+9900.0% | $53.9M+23134.2% | $31.6M+2667.1% |
| Depreciation & Amortization | $56.0M+207307.4% | $47.3M+47200.0% | $41.4M | $40K | $27K-73.0% | $100K-58.3% | $0-100.0% | $0-100.0% |
| Stock-Based Compensation | $29.0M-55.4% | $39.2M+94.1% | N/A | $31.1M+122.1% | $65.0M | $20.2M | N/A | $14.0M |
| Capital Expenditures | $31.5M+158558.2% | $22.5M+15311.0% | $28.4M+1419900.0% | $30K | $20K-49.1% | $146K+139.3% | $2K-95.7% | $0-100.0% |
| Free Cash Flow | -$248.1M-127553.7% | $48.1M+32.3% | $158.2M+193.5% | $183K-99.4% | -$194K+82.4% | $36.4M+11858.6% | $53.9M+19349.3% | $31.6M+2796.4% |
| Investing Cash Flow | -$2.0B-18769.6% | -$19.5M-2337.5% | -$25.9M | -$28K | -$10.6M-27015.9% | -$800K-1211.5% | $0+100.0% | $0+100.0% |
| Financing Cash Flow | $4.9B+62004.1% | $633.9M+2917.3% | -$105.8M-370.2% | -$155K-100.0% | $7.9M-99.2% | -$22.5M-13213.6% | -$22.5M-12540.4% | $4.0B+301196.2% |
| Dividends Paid | N/A | N/A | $0 | $0 | N/A | N/A | $0-100.0% | $0-100.0% |
Not reported in any period shown, so not listed: Share Buybacks.
QXO-PB Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 24.7%+3.7pp | 23.7%-16.3pp | N/A | 23.3%-18.7pp | 21.0%-19.0pp | 40.0%+0.8pp | N/A | 42.0%+2.1pp |
| Operating Margin | -1.3%+7.3pp | -14.6% | N/A | 0.9% | -8.6%+21.1pp | -291.1% | N/A | -257.3% |
| Net Margin | -1.7%+1.4pp | -13.1%-78.3pp | N/A | -5.1% | -3.1%+1.0pp | 65.2%+64.2pp | N/A | 131.3% |
| Return on Equity | -0.5%+0.1pp | -2.2%-2.4pp | N/A | -1.4%-1.8pp | -0.6%-0.5pp | 0.2%-1.6pp | N/A | 0.3%+30.3pp |
| Return on Assets | -0.2%-0.2pp | -1.4%-1.4pp | N/A | 0.0%0.0pp | 0.0%0.0pp | 0.0%0.0pp | N/A | 0.0%+11.5pp |
| Current Ratio | 4.11+1.1x | 3.33-91.9x | 3.58-109.3x | 3.06-255.6x | 3.00-58.8x | 95.23+94.2x | 112.85+111.8x | 258.64+257.6x |
| Debt-to-Equity | 0.58+0.3x | 0.30+0.3x | 0.31+0.3x | 0.31+0.3x | 0.31+0.3x | 0.01-0.1x | 0.00-0.1x | 0.00-0.1x |
| Asset Turnover | 0.140.0x | 0.10+0.1x | N/A | 0.16+0.2x | 0.11+0.1x | 0.00-0.7x | N/A | 0.00-0.7x |
| FCF Margin | -7.6%+2.6pp | 2.8% | N/A | 6.7% | -10.2%-2.6pp | 269.3% | N/A | 241.2% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Where QXO, Inc. Ranks
Frequently Asked Questions
What is QXO, Inc.'s annual revenue?
QXO, Inc. (QXO-PB) reported $6.8M in total revenue for fiscal year 2025. This represents a 11925.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is QXO, Inc.'s revenue growing?
QXO, Inc. (QXO-PB) revenue grew by 11925.0% year-over-year, from $57K to $6.8M in fiscal year 2025.
Is QXO, Inc. profitable?
No, QXO, Inc. (QXO-PB) reported a net income of -$279K in fiscal year 2025, with a net profit margin of -4.1%.
What is QXO, Inc.'s EBITDA?
QXO, Inc. (QXO-PB) had EBITDA of -$137K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does QXO, Inc. have?
As of fiscal year 2025, QXO, Inc. (QXO-PB) had $2.4M in cash and equivalents against $3.1M in long-term debt.
What is QXO, Inc.'s gross margin?
QXO, Inc. (QXO-PB) had a gross margin of 23.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is QXO, Inc.'s operating margin?
QXO, Inc. (QXO-PB) had an operating margin of -3.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is QXO, Inc.'s net profit margin?
QXO, Inc. (QXO-PB) had a net profit margin of -4.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is QXO, Inc.'s return on equity (ROE)?
QXO, Inc. (QXO-PB) has a return on equity of -2.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is QXO, Inc.'s free cash flow?
QXO, Inc. (QXO-PB) generated $183K in free cash flow during fiscal year 2025. This represents a 116.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is QXO, Inc.'s operating cash flow?
QXO, Inc. (QXO-PB) generated $261K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are QXO, Inc.'s total assets?
QXO, Inc. (QXO-PB) had $15.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are QXO, Inc.'s capital expenditures?
QXO, Inc. (QXO-PB) invested $78K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is QXO, Inc.'s current ratio?
QXO, Inc. (QXO-PB) had a current ratio of 3.58 as of fiscal year 2025, which is generally considered healthy.
What is QXO, Inc.'s debt-to-equity ratio?
QXO, Inc. (QXO-PB) had a debt-to-equity ratio of 0.31 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is QXO, Inc.'s return on assets (ROA)?
QXO, Inc. (QXO-PB) had a return on assets of -1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is QXO, Inc.'s Piotroski F-Score?
QXO, Inc. (QXO-PB) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are QXO, Inc.'s earnings high quality?
QXO, Inc. (QXO-PB) reported a net loss of $279K while generating $261K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can QXO, Inc. cover its interest payments?
QXO, Inc. (QXO-PB) reported an operating loss of $245K against $174K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.